Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 361-370 of 406 for multiple

Edit search filters
  1. A Study Of The Safety And Drug/Body Interactions Of BGB-3111 For Patients With B-Cell Lymphoid Malignancies

    Rochester, MN

  2. 24-Week Study To Assess The PD, Safety, Tolerability, And PK Of GLM101 In Adults With PMM2-CDG

    Rochester, MN

  3. MC200404, Safety And Immunogenicity Of PolyPEPI1018 Vaccine In The Treatment Of Late-stage Metastatic Colorectal Cancer

    Rochester, MN

  4. Multiple System Atrophy And Caregivers And What Constitutes Meaningful Change On The Umsars-I Scale

    Rochester, MN

  5. Low-Dose Selinexor And Choline Salicylate For The Treatment Of Patients With Non-Hodgkin Lymphoma Or Histiocytic/Dendritic Cell Neoplasms

    Rochester, MN

  6. A Study Of Intravitreal REGN2176-3 In Patients With Neovascular ("Wet") Age-Related Macular Degeneration

    Jacksonville, FL

  7. A Study To Investigate The Safety And Pharmacokinetics Of ABBV-CLS-7262 In Patients With Amyotrophic Lateral Sclerosis

    Jacksonville, FL, Rochester, MN

  8. A Study Of Crenezumab In Participants With Mild To Moderate Alzheimer Disease

    Scottsdale/Phoenix, AZ

  9. A Study Of MicroRNAs In Patients With Multiple Myeloma Treaded With Immunomodulatory Drugs

    Scottsdale/Phoenix, AZ

  10. Relating Clinical Outcomes In Multiple Myeloma To Personal Assessment Of Genetic Profile

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

.

Mayo Clinic Footer